IL111596A - Process for the preparation of Claudront and pharmaceutical preparations containing it - Google Patents

Process for the preparation of Claudront and pharmaceutical preparations containing it

Info

Publication number
IL111596A
IL111596A IL11159694A IL11159694A IL111596A IL 111596 A IL111596 A IL 111596A IL 11159694 A IL11159694 A IL 11159694A IL 11159694 A IL11159694 A IL 11159694A IL 111596 A IL111596 A IL 111596A
Authority
IL
Israel
Prior art keywords
weight
clodronate
process according
disodium
disodium clodronate
Prior art date
Application number
IL11159694A
Other languages
English (en)
Hebrew (he)
Other versions
IL111596A0 (en
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of IL111596A0 publication Critical patent/IL111596A0/xx
Publication of IL111596A publication Critical patent/IL111596A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ceramic Products (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Glass Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Peptides Or Proteins (AREA)
  • Seasonings (AREA)
  • Glanulating (AREA)
IL11159694A 1993-11-12 1994-11-10 Process for the preparation of Claudront and pharmaceutical preparations containing it IL111596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI935019A FI94926C (fi) 1993-11-12 1993-11-12 Menetelmä klodronaattivalmisteen valmistamiseksi

Publications (2)

Publication Number Publication Date
IL111596A0 IL111596A0 (en) 1995-01-24
IL111596A true IL111596A (en) 1998-12-06

Family

ID=8538945

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11159694A IL111596A (en) 1993-11-12 1994-11-10 Process for the preparation of Claudront and pharmaceutical preparations containing it

Country Status (25)

Country Link
US (1) US5776499A (de)
EP (1) EP0727983B1 (de)
JP (1) JPH09504800A (de)
KR (1) KR100352155B1 (de)
CN (1) CN1040945C (de)
AT (1) ATE202700T1 (de)
AU (1) AU679586B2 (de)
CA (1) CA2175994A1 (de)
CZ (1) CZ286132B6 (de)
DE (1) DE69427648T2 (de)
DK (1) DK0727983T3 (de)
ES (1) ES2160688T3 (de)
FI (1) FI94926C (de)
GR (1) GR3036470T3 (de)
HU (1) HU220633B1 (de)
IL (1) IL111596A (de)
NO (1) NO312938B1 (de)
NZ (1) NZ275833A (de)
PL (1) PL176658B1 (de)
PT (1) PT727983E (de)
RU (1) RU2141323C1 (de)
SK (1) SK280552B6 (de)
TW (1) TW436297B (de)
WO (1) WO1995013054A1 (de)
ZA (1) ZA948974B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
DE19808634A1 (de) * 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
AR021347A1 (es) * 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
RO121891B1 (ro) 2001-07-04 2008-07-30 Sindan S.R.L. Compoziţie farmaceutică pentru profilaxia şi tratamentul dereglărilor metabolismului calciului şi procedeu de preparare
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
GB0616794D0 (en) * 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
US10815558B2 (en) * 2015-12-22 2020-10-27 Stock Company “Chepetsky Mechanical Plant” (SC CMP) Method for preparing rods from titanium-based alloys
CN111565725A (zh) 2017-11-22 2020-08-21 生物运动有限公司 基于c-maf状态的乳腺癌的治疗性处理
TWI806467B (zh) 2022-03-03 2023-06-21 金兆豐數位科技股份有限公司 金融商品提昇報酬率多維度決策方法
EP4445909A1 (de) 2023-04-14 2024-10-16 Università Degli Studi Magna Graecia Catanzaro Pharmazeutische formulierung aus einem c-peptid in kombination mit einem bisphosphonat in einer einzelnen form und ihre verwendung bei der behandlung von osteosarcopenie

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
SK281193B6 (sk) * 1993-05-15 2001-01-18 Roche Diagnostics Gmbh Tableta so zlepšenou biodostupnosťou účinnej látky, kyseliny klodrónovej, spôsob jej výroby a použitie mikrokryštalickej celulózy

Also Published As

Publication number Publication date
HU220633B1 (hu) 2002-03-28
FI94926B (fi) 1995-08-15
EP0727983B1 (de) 2001-07-04
CN1134664A (zh) 1996-10-30
FI935019A0 (fi) 1993-11-12
GR3036470T3 (en) 2001-11-30
FI94926C (fi) 1995-11-27
US5776499A (en) 1998-07-07
CN1040945C (zh) 1998-12-02
PL176658B1 (pl) 1999-07-30
HU9601257D0 (en) 1996-07-29
KR100352155B1 (ko) 2002-12-31
PT727983E (pt) 2001-11-30
NO961906D0 (no) 1996-05-10
NO312938B1 (no) 2002-07-22
PL314299A1 (en) 1996-09-02
FI935019A (fi) 1995-05-13
ATE202700T1 (de) 2001-07-15
AU679586B2 (en) 1997-07-03
RU2141323C1 (ru) 1999-11-20
DE69427648T2 (de) 2002-04-18
CZ286132B6 (cs) 2000-01-12
KR960705548A (ko) 1996-11-08
NO961906L (no) 1996-05-23
TW436297B (en) 2001-05-28
SK60696A3 (en) 1997-02-05
DE69427648D1 (de) 2001-08-09
ES2160688T3 (es) 2001-11-16
HUT75228A (en) 1997-04-28
IL111596A0 (en) 1995-01-24
EP0727983A1 (de) 1996-08-28
JPH09504800A (ja) 1997-05-13
SK280552B6 (sk) 2000-03-13
CA2175994A1 (en) 1995-05-18
NZ275833A (en) 1997-10-24
DK0727983T3 (da) 2001-09-24
AU8108794A (en) 1995-05-29
CZ132796A3 (en) 1996-10-16
WO1995013054A1 (en) 1995-05-18
ZA948974B (en) 1995-11-21

Similar Documents

Publication Publication Date Title
JP3589977B2 (ja) 活性成分としてクロドロン酸塩および賦形剤としてケイ化微晶質セルロースを含む医薬製剤
US5211958A (en) Pharmaceutical composition and process for its preparation
US4632843A (en) Process for the preparation of solid pharmaceutical products
EP0301006B1 (de) Methylprednisolon/natriumcarboxymethylstärke-tablettenmischung
JP2008531737A (ja) アリピプラゾールの湿式造粒医薬組成物
US5460829A (en) Pharmaceutical compositions based on ebastine or analogues thereof
JP2020203918A (ja) トホグリフロジンを含有する固形製剤及びその製造方法
US5776499A (en) Process for preparing a clodronate preparation
JP2019530727A (ja) ラモトリギンを含む経口懸濁液用の粉末
JP2002532429A (ja) 薬学的処方物
AU611740B2 (en) Pharmaceutical composition and process for its preparation
CN105407875A (zh) 包含异烟肼颗粒和利福喷汀颗粒的呈包衣片剂形式的抗结核病的稳定的药物组合物及其制备方法
KR20190047239A (ko) 바제독시펜 또는 그의 약제학적으로 허용가능한 염 및 콜레칼시페롤 또는 그의 약제학적으로 허용가능한 염을 포함하는, 습식과립법을 이용하여 제조되는 복합제제

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed